Investor Relations

Press Release

March 8, 2023

Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

More
February 28, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022

More
February 22, 2023

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023

More
November 22, 2022

Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference

More
November 10, 2022

Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference

More
November 7, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022

More
October 28, 2022

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022

More
September 2, 2022

Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference

More
August 16, 2022

Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes

More
August 8, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022

More
Youtube